Global In-Vitro Diagnostics Technologies and Markets, 2022

Global In-Vitro Diagnostics Technologies and Markets, 2022

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

SOURCE Research and Markets

DUBLIN, Jan. 2, 2018 /PRNewswire/ --

The "In Vitro Diagnostics: Technologies and Global Markets" report has been added to Research and Markets' offering.

Research and Markets Logo

The Global in Vitro Diagnostics (IVD) Market Should Reach $102.4 Billion by 2022 from $74.1 Billion in 2017 at a CAGR of 6.7%, from 2017 to 2022

This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in- depth study of the various in vitro diagnostics (IVD). Segments include clinical chemistry, immunoassays, point-of-care diagnostics, molecular diagnostics, hematology, microbiology and tissue diagnostics.

This report provides a complete review and analysis of the current trends in the IVD markets, along with industry growth drivers and restraints. Revenues are broken down by regions, segments, products and end users, and sales figures have been estimated for the five-year period from 2017 through 2022 in constant U.S. dollars.

In addition, it provides an examination and description of select products, current and emerging technologies, and company profiles. Applications for IVD are also discussed, with an emphasis on the use of these types of tests in various disease sectors. Further, the report offers a view on IVD patents, regulatory aspects and emerging developments in the IVD market across the globe.

Report highlights:

  • The global in vitro diagnostics (IVD) market should reach $102.4 billion by 2022 from $74.1 billion in 2017 at a compound annual growth rate (CAGR) of 6.7%, from 2017 to 2022.
  • The North America region of the global IVD market is the largest market. The market is expected to grow from $31.1 billion in 2017 to $36.9 billion in 2022 at a CAGR of 3.4% for the period 2017-2022.
  • The Asia-Pacific region of the global IVD market is expected to grow from $18.5 billion in 2017 to $34.8 billion in 2022 at a CAGR of 13.5% for the period 2017-2022.

Key Topics Covered:

1 Introduction

2 Summary and Highlights
Global Market Trends

3 Market Landscape
Market Overview and Segmentation
Key Findings
Factors Influencing the Global IVD Market
Regulatory Landscape

4 Market Breakdown by Product Segment
POC Testing
Molecular Diagnostics
Clinical Microbiology
Tissue Diagnostics
Trends in IVD Segments
Competitive Structure
Market Share Analysis

5 Global Immunochemistry Market
Blood Gas, Electrolytes and Metabolites (BGEM)
Infectious Diseases
Blood Screening

6 Global POC Testing Market
Glucose Testing
Cardiac Marker Testing
Infectious Disease Testing
Pregnancy and Fertility Testing
Drug and Alcohol Abuse Testing
Hematology and Hemostasis Testing
Cholesterol Testing
Urine Chemistry Testing
Tumor Marker Testing
Other POC Testing

7 Global Hematology Market
Routine Hematology Tests

8 Global Molecular Diagnostics Market
Infectious Diseases
Blood Screening
Genetic Testing
Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases)

9 Global Clinical Microbiology Market
Blood Culture
General Culture (urine/saliva/stool/sputum/CSF and other Body fluids)
Identification and Antibiotic Susceptibility Testing

10 Global Tissue Diagnostics Market
Cancer Diagnosis
Tissue Typing
Pathogen Detection

11 Market Breakdown by End Users

12 Global IVD Market Products

13 Regional Analysis

14 Emerging Global Technology and Trends
Industry Developments
Opportunity Areas
IVD for Neglected Infectious Diseases
Portable Devices Compatible with Simple Detection Platforms
Chemistry-Based Portable Analyzers
Improved Sample Preservation Technologies
New Detection Technologies
Alternative Technologies to PCR
Key Biomarkers for Diseases of the Developing World
Microfluidic Platform-based POC Tests for Remote Settings
Combining Multiple Detection Technologies into a Single Instrument

15 Mergers and Acquisitions

16 Patent Review
Point of Care Testing
Molecular Diagnostics
Clinical Microbiology
Tissue Diagnostics

17 Company Profiles
Abbott Diagnostics Inc.
Alere San Diego Inc.
Ascensia Diabetes Care
Beckman Coulter (Part of Danaher)
Becton Dickinson and Company
Elitech Group
Hologic Inc.
Kem-En-Tec Diagnostics A/S
Ortho Clinical Diagnostics
Roche Diagnostics Corp.
Siemens Healthcare Diagnostics Inc.
Thermo Fisher Scientific Inc.
Transasia Bio-Medicals
Werfen Group

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

©2017 PR Newswire. All Rights Reserved.

Powered by Frankly